ALK-Abelló A/S (CPH:ALK.B)
Denmark · Delayed Price · Currency is DKK 220.00
+10.00 (4.76%)
Feb 27, 2026, 3:41 PM CET
ALK-Abelló Market Cap
ALK-Abelló has a market cap or net worth of 46.53 billion as of February 27, 2026. Its market cap has increased by 31.47% in one year.
Market Cap
46.53B
Enterprise Value
45.71B
Revenue
6.31B
Ranking
n/a
PE Ratio
38.89
Stock Price
220.00
Market Cap Chart
Since December 27, 2005, ALK-Abelló's market cap has increased from 6.91B to 46.53B, an increase of 573.54%. That is a compound annual growth rate of 9.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 46.44B | -8.16% |
| Dec 30, 2025 | 50.56B | 43.68% |
| Dec 30, 2024 | 35.19B | 57.21% |
| Dec 29, 2023 | 22.38B | 5.48% |
| Dec 30, 2022 | 21.22B | -43.63% |
| Dec 30, 2021 | 37.65B | 37.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.06T |
| Genmab | 112.95B |
| Coloplast | 108.35B |
| Demant | 41.23B |
| H. Lundbeck | 37.23B |
| Zealand Pharma | 25.42B |
| Ambu A/S | 21.13B |
| Bavarian Nordic | 15.25B |